PPARγ-dependent pathway in the growth-inhibitory effects of K562 cells by carotenoids in combination with rosiglitazone

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 1, 2014, Pages 545-555

  Zhao, Han ^a   Gu, Huihui ^a   Zhang, Han ^a   Li, Jun Hui ^a   Zhao, Wen En ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Carotenoid; K562 cell; PPAR ; Rosiglitazone

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ASTAXANTHIN; BETA CAROTENE; BIXIN; CAROTENOID; CYCLIN D1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P21; ROSIGLITAZONE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL STRAIN K 562; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

CAROTENOID; K562 CELL; PPARΓ; ROSIGLITAZONE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CAROTENOIDS; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; HYPOGLYCEMIC AGENTS; K562 CELLS; PPAR GAMMA; RNA, SMALL INTERFERING; THIAZOLIDINEDIONES;

EID: 84886731904     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.09.005     Document Type: Article

References (45)

1. F. Baldrick, J. Woodside, J. Elborn, I. Young, and M. McKinley Biomarkers of fruit and vegetable intake in human intervention studies: a systematic review Crit. Rev. Food Sci. 51 2011 795 815
2. H. Boeing, A. Bechthold, A. Bub, S. Ellinger, D. Haller, A. Kroke, E. Leschik-Bonnet, M.J. Muller, H. Oberritter, M. Schulze, P. Stehle, and B. Watzl Critical review: vegetables and fruit in the prevention of chronic diseases Eur. J. Nutr. 51 2012 637 663
3. L. Gallicchio, K. Boyd, G. Matanoski, X. Tao, L. Chen, T.K. Lam, M. Shiels, E. Hammond, K.A. Robinson, L.E. Caulfield, J.G. Herman, E. Guallar, and A.J. Alberg Carotenoids and the risk of developing lung cancer: a systematic review Am. J. Clin. Nutr. 88 2008 372 383
4. C.S. Huang, J.W. Liao, and M.L. Hu Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice J. Nutr. 138 2008 538 543
5. F. Lian, K. Hu, R.M. Russell, and X. Wang β-Cryptoxanthin suppresses the growth of immortalized human bronchial epithelial cells and non-small-cell lung cancer cells and up-regulates retinoic acid receptor β expression Int. J. Cancer 119 2006 2084 2089
6. R.M. Tamimi, G.A. Colditz, and S.E. Hankinson Circulating carotenoids, mammographic density, and subsequent risk of breast cancer Cancer Res. 69 2009 9323 9329
7. P. Palozza, R. Simone, and M.C. Mele Interplay of carotenoids with cigarette smoking: implications in lung cancer Curr. Med. Chem. 15 2008 844 854
8. M. Touvier, E. Kesse, F. Clavel-Chapelon, and M.C. Boutron-Ruault Dual association of beta-carotene with risk of tobacco-related cancers in a cohort of French women J. Natl. Cancer Inst. 97 2005 1338 1344
9. M. Lehrke, and M.A. Lazar The many faces of PPAR gamma Cell 123 2005 993 999
10. I. Sainis, K. Vareli, V. Karavasilis, and E. Briasoulis PPARγ: the portrait of a target ally to cancer chemopreventive agents PPAR Res. 2008 2008 294 304
11. S. Han, and J. Roman Peroxisome proliferator-activated receptor [gamma]: a novel target for cancer therapeutics Anti Cancer Drugs 18 2007 237 244
12. F. Ondrey Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention Clin. Cancer Res. 15 2009 2 8
13. H.P. Koeffler Peroxisome proliferator-activated receptor gamma and cancers Clin. Cancer Res. 9 2003 1 9
14. S. Han, and J. Roman Anticancer actions of PPARγ ligands: current state and future perspectives in human lung cancer World J. Biol. Chem. 1 2010 31 40
15. C.M. Lyon, D.M. Klinge, K.C. Do, M.J. Grimes, C.L. Thomas, L.A. Damiani, T.H. March, C.A. Stidley, and S.A. Belinsky Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model Carcinogenesis 30 2009 2095 2099
16. J. Liu, T. Hu, X. Wu, C. Wang, Y. Xu, Y. Zhang, R. Xiao, D. Lin, R. Huang, and Q. Liu Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone-induced apoptosis in leukemia K562 cells and its mechanisms of action Int. J. Toxicol. 28 2009 123 131
17. Y. Cui, Z. Lu, L. Bai, Z. Shi, W. Zhao, and B. Zhao β-Carotene induces apoptosis and up-regulates peroxisome proliferators-activated γ expression and reactive oxygen species production in MCF-7 cancer cells Eur. J. Cancer 43 2007 2590 2601
18. X. Zhang, W. Zhao, L. Hu, L. Zhao, and J. Huang Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma (PPARγ) in K562 cancer cells Arch. Biochem. Biophys. 512 2011 96 106
19. W. Zhao, X. Zhang, and P. Guo Carotenoids inhibit cell proliferation and up-regulate PPARγ expression in K562 cells Acta Biophys. Sin. S1 2009 420
20. L. Cerquetti, C. Sampaoli, D. Amendola, B. Bucci, L. Masuelli, R. Marchese, S. Misiti, A.D. Venanzi, and M. Poggi Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells Exp. Cell Res. 317 2011 1397 1410
21. R. Miao, T. Xu, L. Liu, M. Wang, Y. Jiang, J. Li, and R. Guo Rosiglitazone and retinoic acid inhibit proliferation and induce apoptosis in the HCT-15 human colorectal cancer cell line Exp. Ther. Med. 2 2011 413 417
22. T. Araki, M. Varadinova, M. Goldman, Z. Rosenwaks, L. Poretsky, and D.S. Young Rosiglitazone and pioglitazone alter aromatase kinetic properties in human granulosa cells PPAR Res. 2011 2011 1 5
23. C. Freudlsperger, A. Dahl, J. Hoffmann, S. Reinert, and U. Schumacher Mistletoe lectin-I augments anti-proliferative effects of the PPAR gamma agonist rosiglitazone on human malignant melanoma cells Phytother. Res. 24 2010 1354 1358
24. J. Liu, X. Yan, Y. Zhang, R. Xiao, and D. Lin Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist rosiglitazone (RGZ) inhibits HL-60 cell growth by induction of apoptosis Lab. Med. 40 2009 297 302
25. A. Heath, and S.Y. Elrod Sun, PPARγ and apoptosis in cancer PPAR Res. 2008 2008 641 653
26. C.M. Yang, I.H. Lu, H.Y. Chen, and M.L. Hu Lycopene inhibits the proliferation of androgen-dependent human prostate tumor cells through activation of PPARγ-LXRα-ABCA1 pathway J. Nutr. Biochem. 23 2012 8 17
27. C.M. Yang, I.H. Lu, H.Y. Chen, and M.L. Hu Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway J. Nutr. Biochem. Nov 30 2011
28. S.S. Chellappan, A. Giordano, and P.B. Fisher Role of cyclin dependent kinases and their inhibitors in cellular differentiation and development Curr. Top. Microbiol. Immunol. 227 1998 57 103
29. C. Grommes, G.E. Landreth, and M.T. Heneka Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists Lancet Oncol. 5 2004 419 429
30. M. Toyota, Y. Miyazaki, S. Kitamura, and Y. Nagasawa Peroxisome proliferator-activated receptor γ reduces the growth rate of pancreatic carcinoma cells through the reduction of cyclin D1 Life Sci. 70 2002 1565 1575
31. S. Han, N. Sidell, P.B. Fisher, and J. Roman Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor γ in human lung carcinoma cells Clin. Cancer Res. 10 2004 1911 1919
32. T.H. Chang, and E. Szabo Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-γ and inhibitors of histone deacetylase in adenocarcinoma of the lung Clin. Cancer Res. 8 2002 1206 1212
33. A.G. Smith, K.A. Beaumont, D.J. Smit, A.E. Thuiber, A.L. Cook, G.M. Boyle, P.G. Parsons, R.A. Sturm, and G.E.O. Muscat PPARγ agonist attenuate proliferation and modulate Wnt/β-catenin signaling in melanoma cells Int. J. Biochem. Cell Biol. 41 2009 844 852
34. H. Kameji, K. Mochizuki, N. Miyoshi, and T. Goda β-Carotene accumulation in 3 T3-L1 adipocytes inhibits the elevation of reactive oxygen species and the suppression of genes related to insulin sensitivity induced by tumor necrosis factor-alpha Nutrition 26 2010 1151 1156
35. A. Harari, D. Harats, D. Marko, H. Cohen, I. Barshack, Y. Kamari, A. Gonen, Y. Gerber, A. Ben-Amotz, and A. Shaish A 9-cis β-carotene-enriched diet inhibits atherogenesis and fatty liver formation in LDL receptor knockout mice J Nutr. 138 2008 1923 1930
36. J. Amengual, E. Gouranton, Y.G.J. van Helden, S. Hessel, J.R. Kramer, B. Kiec-Wilk, U. Razny, G. Lietz, A. Wyss, A. Dembinska-Kiec, A. Palou, J. Keijer, J.F. Landrier, M.L. Bonet, and J. von Lintig Beta-carotene reduces body adiposity of mice via BCMO1 PLoS One 6 2011 e20644
37. N. Takahashi, T. Goto, A. Taimatsu, K. Egawa, S. Katoh, T. Kusudo, T. Sakamoto, C. Ohyane, J.Y. Lee, Y.I. Kim, T. Uemura, S. Hirai, and T. Kawada Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3 T3-L1 adipocytes through PPAR Biochem. Biophys. Res. Commun. 390 2009 1372 1376
38. S. Zaripheh, T.Y. Nara, M.T. Nakamura, and J.W. Erdman Jr Dietary lycopene downregulates carotenoid 15,15′-monooxygenase and PPAR-γ in selected rat tissues J. Nutr. 136 2006 4932 4938
39. R.E. Simone, M. Russo, A. Catalano, G. Monego, K. Froehlich, V. Boehm, and P. Palozza Lycopene inhibits NF-kB-mediated IL-8 expression and changes redox and PPARγ signalling in cigarette smoke-stimulated macrophages PLoS One 6 2011 e19652
40. P. Palozza, R. Simone, A. Catalano, G. Monego, A. Barini, M.C. Mele, N. Parrone, S. Trombino, N. Picci, and F.O. Ranelletti Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF-κB nuclear binding and increase in PPARγ expression J. Nutr. Biochem. 22 2011 259 268
41. P. Palozza, R. Simone, A. Catalano, N. Parrone, G. Monego, and F.O. Ranelletti Lycopene regulation of cholesterol synthesis and efflux in human macrophages J. Nutr. Biochem. 22 2011 971 978
42. K.K. Ryan, B.E. Grayson, K.R. Jones, A.L. Schneider, S.C. Woods, R.J. Seeley, J.P. Herman, and Y.M. Ulrich-Lai Physiological responses to acute psychological stress are reduced by the PPARgamma agonist rosiglitazone Endocrinology 153 2012 1279 1287
43. S. Han, and J. Roman Rosiglitazone suppresses human carcinoma cell growth through PPARγ-dependent and PPARγ-independent signal pathways Mol. Cancer Ther. 5 2006 430 437
44. M. Li, T.W. Lee, A.P.C. Yim, T.S.K. Mok, and G.G. Chen Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor γ and ERK-dependent in human non-small lung cancer cells J. Cell. Physiol. 209 2006 428 438
45. M. Saiki, Y. Hatta, T. Yamazaki, T. Itoh, Y. Enomoto, J. Takeuchi, U. Sawada, S. Aizawa, and T. Horie Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells Int. J. Oncol. 29 2006 437 443